Vaxart
+$1.57 (+21.90%) Today
+$0.02 (+0.23%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Vaxart and other stocks, options, and ETFs commission-free!
About VXRT
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus.
CEO
Andrei Floroiu
Employees
28
Headquarters
South San Francisco, California
Founded
2004
VXRT Key Statistics
Market Cap
1.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
15.87M
High Today
$10.00
Low Today
$7.44
Open Price
$7.53
Volume
104.10M
52 Week High
$24.90
52 Week Low
$2.25
VXRT News
VXRT Earnings
-$0.32
-$0.21
-$0.11
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market